In-Soo Choi

Title: In-Soo Choi: Innovator in Feline Immunology

Introduction

In-Soo Choi is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of immunology, particularly concerning feline health. His work has led to advancements that could enhance the immune response in cats.

Latest Patents

In-Soo Choi holds a patent for "Feline CD86 polypeptides and nucleic acids." This invention provides isolated and purified DNA encoding feline CD80 (B7-1) ligand, feline CD86 (B7-2) ligand, feline CD28 receptor, and feline CTLA-4 (CD152) receptor. The patent also includes vectors comprising nucleic acid encoding these components. Furthermore, it describes host cells transformed with CD80-encoding vectors, CD86-encoding vectors, CD28-encoding vectors, or CTLA-4-encoding vectors. The invention offers polypeptides encoded by the nucleic acid of feline CD80, feline CD86, feline CD28, or feline CTLA-4. Additionally, it provides a vaccine comprising an effective amount of these polypeptides, which can enhance or suppress immune responses.

Career Highlights

In-Soo Choi has worked with reputable organizations, including the Texas A&M University System and Intervet Inc. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to significant research.

Collaborations

Some of his notable coworkers include Ellen W. Collisson and Barbara J. Winslow. Their collaborative efforts have furthered research in feline immunology and related areas.

Conclusion

In-Soo Choi's innovative work in feline immunology has the potential to improve the health and well-being of cats through enhanced vaccines and immune responses. His contributions are invaluable to the field and highlight the importance of research in veterinary medicine.